Coronaviruses Research in BRICS Countries

Coronaviruses Research in BRICS Countries

SARS-CoV-2 has infected more than 105 million people worldwide. During this pandemic, researchers and clinicians have been working to understand the molecular mechanisms that underpin viral pathogenesis by studying viral-host interactions. Now, with the global rollout of various COVID-19 vaccines-ba...

Full description

Bibliographic Details
Format:	eBook
Language:	English
Published:	Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:	Epidemiology and Medical statistics Medicine and Nursing aerosol bioinformatics and vaccine development Brazil breakthrough convalescent plasma coronavirus disease 2019 (COVID-19) corticosteroids COVID-19 COVID-19 and nanotechnology COVID-19 testing Delta and Delta plus variant dental aerosol-generating procedures detection diabetes different settings E484K epitope coverage extra-oral suction genomic epidemiology high-volume evacuation hospital mortality humoral response immunoassay India intervention strategies intubation low-volume saliva ejector models nanomedicine in South Africa nanotechnology neutralizing antibody (NAb) NSW protein microarray quantitative antibody binding reverse zoonosis SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 nucleocapsid protein severe acute respiratory syndrome coronavirus (SARS-CoV-2) splatter treatment vaccine vaccine development in South Africa variant of Interest VRDL wildlife
Online Access:	Open Access: DOAB: description of the publication Open Access: DOAB, download the publication

Similar Items

Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2
by: Theocharis G. Konstantinidis, et al.
Published: (2021-06-01)

Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
by: Elaine C. Chen, et al.
Published: (2021-08-01)

The immune system view of the coronavirus SARS-CoV-2
by: Ivana Celardo, et al.
Published: (2020-12-01)

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
by: Giuseppe Novelli, et al.
Published: (2021-05-01)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
by: Etienne Brochot, et al.
Published: (2020-10-01)

Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients
by: Josef Singer, et al.
Published: (2021-08-01)

Characteristics and outcomes of vaccinated and nonvaccinated patients hospitalized in a single Italian hub for COVID-19 during the Delta and Omicron waves in Northern Italy
by: Baldanti, F., et al.
Published: (2022)

Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?
by: Lorenzo Lo Muzio, et al.
Published: (2021-09-01)

The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay
by: Gian Luca Salvagno, et al.
Published: (2021-10-01)

Antibodies and Vaccines Target RBD of SARS-CoV-2
by: Long Min, et al.
Published: (2021-04-01)

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
by: Richard S. Bennett, et al.
Published: (2021-05-01)

Salivary testing of COVID-19: evaluation of serological testing following positive salivary results
by: Lisa Caulley, et al.
Published: (2021-05-01)

Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
by: Isabel Kinney Ferreira De Miranda Santos, et al.
Published: (2020-11-01)

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
by: Isabel Kinney Ferreira de Miranda Santos, et al.
Published: (2020-08-01)

Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
by: Lennox Chitsike, et al.
Published: (2021-07-01)

Vaccines and Therapies in Development for SARS-CoV-2 Infections
by: David Wu, et al.
Published: (2020-06-01)

COVID-19: Look to the Future, Learn from the Past
by: Zhangkai J. Cheng, et al.
Published: (2020-10-01)

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
by: Ebenezer Tumban
Published: (2021-12-01)

Nano‐therapeutic strategies to target coronavirus
by: Mohd Ahmar Rauf, et al.
Published: (2021-06-01)

Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil
by: Cassia F. Estofolete, et al.
Published: (2021-06-01)

A short discussion about the SARS-CoV-2 mRNA-1273 vaccine
by: Bryan Oronsky, et al.
Published: (2021-03-01)

The SARS-CoV-2 outbreak from a one health perspective
by: Maged Gomaa Hemida, et al.
Published: (2020-12-01)

Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients
by: Emanuele Amodio, et al.
Published: (2021-07-01)

Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis
by: Eva Schrezenmeier, et al.
Published: (2021-06-01)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
by: PJ Klasse, et al.
Published: (2020-06-01)

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
by: Lara Schöler, et al.
Published: (2020-10-01)

Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals
by: Hyunsuh Kim, et al.
Published: (2020-11-01)

Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India
by: Taufik Momin, et al.
Published: (2021-08-01)

Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination
by: Gian Luca Salvagno, et al.
Published: (2021-05-01)

Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen
by: Vikram Srivastava, et al.
Published: (2021-03-01)

Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike’s Dynamics
by: Jorge González-Puelma, et al.
Published: (2021-05-01)

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
by: Balasubramanian Ganesh, et al.
Published: (2021-04-01)

The COVID-19 pandemic: is it really just a flu? Focus on epidemiology
by: Claudia Tieri
Published: (2020-12-01)

Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
by: Nathan Peiffer-Smadja, et al.
Published: (2021-08-01)

Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses
by: Monia Makhoul, et al.
Published: (2020-11-01)

Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out
by: Ghina R. Mumtaz, et al.
Published: (2021-06-01)

KG-COVID-19: A Framework to Produce Customized Knowledge Graphs for COVID-19 Response
by: Justin T. Reese, et al.
Published: (2021-01-01)

Commentary: Origin and evolution of pathogenic coronaviruses
by: Shun Adachi, et al.
Published: (2020-04-01)

Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds
by: Philip L Tzou, et al.
Published: (2020-09-01)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
by: Ujjwal Neogi, et al.
Published: (2020-04-01)